Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, August 20, 2025

A Co-designed Digital Device for Tracking Rehabilitation Dosage After Stroke: Validity and Feasibility Study in a Clinical Environment

Why are you incompetently measuring dosage rather than results? Your mentors and senior researchers are that blitheringly stupid?

Send me personal hate mail on this: oc1dean@gmail.com. I'll print your complete statement with your name and my response in my blog. Or are you afraid to engage with my stroke-addled mind? No excuses are allowed! You're medically trained; it should be simple to precisely state EXACTLY WHY you aren't measuring results with NO EXCUSES! Your definition of competence in stroke is obviously much lower than stroke survivors' definition of your competence! Swearing at me is allowed, I'll return the favor. Don't even attempt to use the excuse that brain research is hard.

The latest here:

 A Co-designed Digital Device for Tracking Rehabilitation Dosage After Stroke: Validity and Feasibility Study in a Clinical Environment

Fiona Boyd1 MEng; Gillian Sweeney2* PhD; Mark Barber3* MD; Elaine Forrest2* MD; Mark Dunlop4* PhD; Andrew Kerr1* PhD 1Department of Biomedical Engineering University of Strathclyde Glasgow GB 2South Lanarkshire Stroke and Neuro Team Udston Hospital NHS Lanarkshire Hamilton GB 3Dept of Medicine for the Elderly Monklands Hospital NHS Lanarkshire Airdrie GB 4Department of Computer and Information Sciences University of Strathclyde Glasgow GB *these authors contributed equally

Corresponding Author: Fiona Boyd MEng Department of Biomedical Engineering University of Strathclyde Wolfson Centre 106 Rottenrow Glasgow GB 

 Abstract

Background:

In 2023, the National Clinical Guidelines(This should be protocols; more provable incompetence!) for Stroke revised the recommended daily multidisciplinary therapy dose from 45 minutes to 3 hours.(WHAT INCOMPETENCE; MEASURING DOSAGE RATHER THAN RECOVERY RESULTS! I'd fire all of you!) To monitor the achievement of these guidelines there is a need for accurate measurement. This study introduces a novel co-designed digital dosage tracking system that utilises Near Field Communication (NFC) technology to log rehabilitation activities and demonstrates its feasibility and accuracy in a clinical setting through comparison with the current clinical method of manual recording.

Objective:

This study aimed to assess the validity, feasibility, and usability of a novel co-designed digital tracker using Near Field Communication (NFC) technology to automatically log rehabilitation dosage in stroke patients, providing an objective and low-burden solution for clinical environments.

Methods:

This pilot mixed-methods study included two phases. Phase 1 involved a usability trial with nine participants conducted at a university research centre, assessing usability with the System Usability Scale (SUS) and Intrinsic Motivation Inventory (IMI). Phase 2 consisted of a clinical trial in an NHS stroke ward with 15 inpatients, comparing the digital tracker with manual therapist recordings for validity and feasibility using paired t-tests, Cohen's D, and Bland-Altman plots. An acceptable discrepancy range was set at ±5-10%.

Results:

The digital tracker demonstrated high usability with a mean SUS score of 91.43 (SD = 9.53) and strong user satisfaction (IMI score 6.29/7, SD = 1.50). Clinical trial results showed a strong agreement between the digital and manual methods (t(207)=-1.55, P=.12, Cohen’s D=-0.06), with a small mean time discrepancy of 1.18 minutes (SD = 10.98) across 208 activities. The Bland-Altman plot indicated good accuracy and consistency between methods, with limits of agreement within the clinically acceptable range.

Conclusions:

The co-designed digital tracker has been shown to agree with a manual method for recording rehabilitation dosage. This development presents the opportunity for objective, automated and low-burden recording of rehabilitation dose to support prescription, monitoring and research. Clinical Trial: ClinicalTrials.gov: NCT05981729 IRAS ID No. 329156

Posted by at
Labels: , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)